COVID-19 Impact on Sleep Apnea Diagnostics Market value estimated at $168 Mn by 2025

Increase in incidence of obesity across the globe, rise in number of employees working in shifts as well as under stressful work conditions and high-end technological advancements in sleep apnea diagnostic devices fuel the growth of the global sleep apnea diagnostics market.

According to the report, the global sleep apnea diagnostics market was estimated at $ 99 million in 2017, and is expected to hit $168 million by 2025, growing at a CAGR of 6.8% from 2018 to 2025. The report offers a detailed analysis of the top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, top investment pockets, and changing market trends.

Rise in prevalence of obesity across the globe, increase in number of employees working in shifts as well as under stressful work conditions and technological advancements in sleep apnea diagnostic devices fuel the growth of the global sleep apnea diagnostics market. On the other hand, high cost associated with the sleep apnea diagnostic devices and lack of awareness among patients regarding sleep apnea check the growth to some extent. However, untapped markets in developing economies are expected to create a number of opportunities for the key players in the industry.

Download Sample Copy of this Report at https://www.alliedmarketresearch.com/request-sample/4666

The global sleep apnea diagnostics market is classified into product, end-user and region. Based on product, the market is segmented into polysomnography (PSG) device, actigraphy system, respiratory polygraph, sleep apnea screening device, and oximeter. Based on end-user, the report divides into hospitals & sleep laboratories and home care settings. Based on region, the report is studied across North America, Europe, Asia-Pacific, and LAMEA.

Based on product, the polysomnography (PSG) device segment dominated the global sleep apnea diagnostics market in 2017, and is anticipated to rule the roost during the study period. The actigraphy monitoring device segment, on the other hand, is projected to grow at the highest CAGR of 7.5% from 2018 to 2025. Based on end user, the home care settings segment would showcase the fastest CAGR of 7.2% by 2025. Based on geography, North America held the major share in 2017, accounting for more than half of the total market.

Check available discounts on this report at https://www.alliedmarketresearch.com/purchase-enquiry/4666

The key players analyzed in the market report include DeVilbiss Healthcare LLC., SomnoMedics, Nihon Kohden Corporation, Resmed, Koninklijke Philips N.V., Cadwell Laboratories Inc., Medtronic plc, Mindray, Natus Medical Incorporated, and Smiths Medical. They have adhered to different strategies including expansions, mergers & acquisitions, partnerships, joint ventures, collaborations, and others to heighten their stand in the market.

Report Attribute	Details
Market size available for years	2018 – 2025
Base year considered	2019
Forecast period	2019 – 2025
Forecast units	Value (USD)
Segments covered	By Product & End-User
Geographies covered	North America, Europe, Asia-Pacific, LAMEA

Related Reports:

Multiplex Assay Market Report – Global Opportunity Analysis and Industry Forecast, 2019–2026

Companion Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2019–2026